Page 30 - Abt Data Science News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Abt data science. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Abt Data Science Today - Breaking & Trending Today

Abbott Laboratories (NYSE:ABT) Shares Sold by Carmel Capital Partners LLC

Carmel Capital Partners LLC reduced its position in Abbott Laboratories (NYSE:ABT – Free Report) by 18.1% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 3,032 shares of the healthcare product maker’s stock after selling 670 shares during the quarter. Carmel Capital Partners LLC’s […] ....

Raymond James , Johna Jr , Royal Bank , Securities Exchange Commission , Abbott Laboratories , Gradient Investments , Rockland Trust Co , Carmel Capital Partners , Visionpoint Advisory Group , Zevenbergen Capital Investments , Perigon Wealth Management , Free Report , Capital Partners , Capital Investments , Wealth Management , Point Advisory Group , Get Free Report , Exchange Commission , Gesua Sive Salvadori , Established Pharmaceutical Products , Diagnostic Products , Nutritional Products , Visit Holdingschannel , Abbott Laboratories Daily , Nyse Abt , Sec Filings ,

Nicholas Hoffman & Company LLC. Raises Holdings in Abbott Laboratories (NYSE:ABT)

Nicholas Hoffman & Company LLC. grew its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 2.8% in the fourth quarter, HoldingsChannel reports. The firm owned 13,787 shares of the healthcare product maker’s stock after buying an additional 377 shares during the quarter. Nicholas Hoffman & Company LLC.’s holdings in Abbott Laboratories were […] ....

Raymond James , Andreaf Wainer , Nicholas Hoffman Company , Abbott Laboratories , Rappaport Reiches Capital Management , Patriot Investment Management Group Inc , Royal Bank , Securities Exchange Commission , Stonebridge Capital Advisors , Shepherd Financial Partners , Nicholas Hoffman , Free Report , Reiches Capital Management , Investment Management Group , Financial Partners , Capital Advisors , Get Free Report , Exchange Commission , Established Pharmaceutical Products , Diagnostic Products , Nutritional Products , Visit Holdingschannel , Abbott Laboratories Daily , Nyse Abt , Sec Filings , Hedge Fund Holdings ,

Arcblock (ABT) Price Down 22.7% Over Last Week

Arcblock (ABT) traded down 2.7% against the dollar during the twenty-four hour period ending at 23:00 PM ET on April 18th. In the last seven days, Arcblock has traded 22.7% lower against the dollar. One Arcblock token can now be purchased for approximately $2.06 or 0.00003421 BTC on cryptocurrency exchanges. Arcblock has a total market […] ....

Hokkaidu Inu , Kitty Inu , Arcblock Token , Arcblock Daily , Currency Arcblock ,

Abbott Laboratories (NYSE:ABT) Shares Sold by Guardian Investment Management

Guardian Investment Management lessened its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 1.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 12,750 shares of the healthcare product maker’s stock after selling 200 shares during the quarter. […] ....

Raymond James , Livforsakringsbolaget Skandia Omsesidigt , Andreaf Wainer , Securities Exchange Commission , Royal Bank , Abbott Laboratories , Daiwa Securities Group Inc , Abbott Laboratories Company Profile , Exchange Commission , Capital Management Inc , Guardian Investment Management , Free Report , Investment Management , Capital Management , Wealth Management , Von Storch , Skandia Omsesidigt , Daiwa Securities Group , Securities Group , Get Free Report , Established Pharmaceutical Products , Diagnostic Products , Nutritional Products , Abbott Laboratories Daily , Nyse Abt , Sec Filings ,

Abbott Laboratories (NYSE:ABT) Posts Quarterly Earnings Results, Beats Estimates By $0.02 EPS

Abbott Laboratories (NYSE:ABT – Get Free Report) released its quarterly earnings data on Wednesday. The healthcare product maker reported $0.98 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.96 by $0.02, RTT News reports. Abbott Laboratories had a return on equity of 20.65% and a net margin of 14.27%. The company […] ....

Raymond James , Andreaf Wainer , Johna Jr , Abbott Laboratories , Morgan Stanley , Vanguard Group Inc , Group Plc , Moneta Group Investment Advisors , Abbott Laboratories Company Profile , Securities Exchange Commission , Norges Bank , Get Free Report , Exchange Commission , Group Investment Advisors , General Group Plc , Established Pharmaceutical Products , Diagnostic Products , Nutritional Products , Abbott Laboratories Daily , Nyse Abt ,